Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Stomach (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank ascending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 3.5 (3.5, 3.6) N/A 13,787 55.7
Wyoming 6 2.2 (1.7, 2.7) 50 (34, 50) 16 50.3
Nevada 6 2.5 (2.3, 2.7) 49 (39, 50) 90 51.0
North Dakota 6 2.6 (2.1, 3.1) 48 (22, 50) 23 54.2
West Virginia 6 2.7 (2.4, 3.0) 47 (27, 50) 71 52.4
New Hampshire 6 2.7 (2.4, 3.1) 46 (24, 50) 51 50.3
Iowa 3 2.7 (2.5, 3.0) 45 (29, 50) 111 59.0
South Dakota 6 2.8 (2.3, 3.3) 44 (16, 50) 30 58.0
Tennessee 6 2.8 (2.6, 3.0) 43 (31, 49) 234 50.9
Utah 3 2.8 (2.5, 3.1) 42 (25, 50) 80 61.0
Idaho 3 2.8 (2.5, 3.2) 41 (22, 50) 58 61.6
Arizona 6 2.8 (2.7, 3.0) 40 (29, 48) 250 53.2
Oklahoma 6 2.9 (2.7, 3.1) 39 (25, 48) 132 53.5
Colorado 6 2.9 (2.7, 3.1) 38 (24, 47) 186 58.0
Oregon 6 3.0 (2.8, 3.2) 37 (22, 47) 159 59.5
Kansas 6 3.0 (2.7, 3.2) 36 (20, 48) 104 57.5
Nebraska 6 3.0 (2.7, 3.3) 35 (16, 48) 69 59.4
Minnesota 6 3.0 (2.8, 3.2) 34 (23, 46) 207 54.3
Arkansas 6 3.0 (2.7, 3.3) 33 (20, 48) 112 50.8
Alabama 6 3.0 (2.8, 3.2) 32 (22, 46) 190 47.3
Virginia 6 3.0 (2.9, 3.2) 31 (22, 43) 309 55.2
Montana 6 3.1 (2.6, 3.5) 30 (10, 49) 43 59.9
Ohio 6 3.1 (3.0, 3.3) 29 (21, 38) 467 54.6
Missouri 6 3.2 (3.0, 3.4) 28 (17, 39) 244 59.2
Michigan 6 3.2 (3.1, 3.4) 27 (18, 35) 419 55.1
Florida 6 3.2 (3.1, 3.3) 26 (19, 32) 977 54.8
Maine 6 3.2 (2.9, 3.6) 25 (8, 46) 66 55.7
Kentucky 3 3.3 (3.1, 3.5) 24 (12, 37) 182 51.8
Vermont 6 3.3 (2.8, 3.9) 23 (4, 48) 29 57.0
New Mexico 3 3.3 (3.0, 3.6) 22 (8, 41) 88 50.1
Washington 5 3.3 (3.2, 3.5) 21 (12, 32) 300 58.9
South Carolina 6 3.4 (3.2, 3.6) 20 (10, 30) 223 55.3
District of Columbia 6 3.4 (2.8, 4.1) 19 (2, 48) 23 47.7
North Carolina 6 3.5 (3.3, 3.6) 18 (10, 26) 436 55.4
Maryland 6 3.5 (3.3, 3.7) 17 (8, 27) 260 51.7
Pennsylvania 6 3.5 (3.4, 3.7) 15 (9, 23) 613 58.9
Delaware 6 3.5 (3.1, 4.1) 14 (3, 40) 45 56.1
Georgia 3 3.6 (3.4, 3.7) 13 (8, 23) 422 54.1
Wisconsin 6 3.6 (3.4, 3.8) 12 (6, 23) 272 60.2
Texas 3 3.7 (3.6, 3.8) 11 (7, 16) 1,088 55.5
Louisiana 3 3.7 (3.5, 4.0) 10 (4, 21) 210 54.6
Mississippi 6 3.8 (3.5, 4.1) 9 (3, 21) 139 56.2
Rhode Island 6 3.8 (3.4, 4.3) 8 (1, 28) 53 56.6
New Jersey 3 3.8 (3.7, 4.0) 7 (4, 14) 442 51.4
Connecticut 3 3.9 (3.7, 4.2) 6 (2, 15) 186 56.3
Illinois 3 4.0 (3.9, 4.2) 5 (3, 10) 617 57.6
Hawaii 3 4.2 (3.8, 4.6) 4 (1, 14) 81 52.9
California 3 4.3 (4.2, 4.4) 3 (1, 5) 1,895 58.4
New York 3 4.5 (4.4, 4.6) 2 (1, 4) 1,116 54.0
Alaska 6 4.5 (3.8, 5.3) 1 (1, 17) 35 65.3
Indiana 6
data not available
N/A
data not available
data not available
Puerto Rico 6 2.8 (2.6, 3.1) N/A 125 43.1
Notes:
Created by statecancerprofiles.cancer.gov on 10/03/2024 8:04 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Puerto Rico

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top